Quarterly report pursuant to Section 13 or 15(d)

STOCKHOLDERS' EQUITY (DEFICIT) (Details 1)

v3.19.1
STOCKHOLDERS' EQUITY (DEFICIT) (Details 1)
3 Months Ended
Mar. 31, 2019
$ / shares
shares
Equity [Abstract]  
Number of options outstanding, beginning | shares 959,375
Number of options granted | shares 4,475,000
Number of options outstanding, ending | shares 5,434,375
Number of options exercisable | shares 3,528,133
Weighted average exercise price outstanding, beginning | $ / shares $ .41
Weighted average exercise price granted | $ / shares .19
Weighted average exercise price outstanding, ending | $ / shares .20
Weighted average exercise price, exercisable | $ / shares $ .27
Weighted average remaining contractual life outstanding, beginning 8 years 9 months 15 days
Weighted average remaining contractual life granted 10 years
Weighted average remaining contractual life outstanding, ending 8 years 7 months 24 days
Weighted average remaining contractual life exercisable 8 years 1 month 6 days